gemigliptin and metformin HCl extended release: Clinical Trials

4 trials of gemigliptin and metformin HCl extended release, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Unknown 1

Follow gemigliptin and metformin HCl extended release: new trials by email Literature Review of gemigliptin and metformin HCl extended release trials Research Report on gemigliptin and metformin HCl extended release

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone
gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl extended release - Healthy
Phase 1UnknownLG Life Sciences252015-08-012016-02-02
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone
gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl extended release - Healthy
Phase 1CompletedLG Life Sciences292014-12-012015-02-03
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.
gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl sustained release - Healthy
Phase 1CompletedLG Life Sciences242014-03-012014-05-08
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone
gemigliptin and metformin HCl extended release, gemigliptin/metformin HCl extended release - Healthy
Phase 1CompletedLG Life Sciences272012-10-012015-04-03

Sponsors

LG Life Sciences (4)

Countries

South Korea (4)

Top investigators

Kyung-sang Yu, M.D,Ph.D (1)

Results publications

PMID 25678778, PMID 30288156